• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

TetraLogic Pharmaceuticals Corp

+ Add to Watchlist


5.0700 USD 0.0300 0.60%

As of 20:10:00 ET on 07/28/2014.

Snapshot for TetraLogic Pharmaceuticals Corp (TLOG)

Open: 5.0200 Day's Range: 4.8600 - 5.1000 Volume: 9,463
Previous Close: 5.0400 52wk Range: 3.8400 - 14.7500 1-Yr Rtn: -

Stock Chart for TLOG

No chart data available.
  • TLOG:US 5.0300
  • 1D
  • 1M
  • 1Y
Interactive TLOG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TLOG

Current P/E Ratio (ttm) -
Estimated P/E(12/2013) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2013) -7.4300
Est. PEG Ratio -
Market Cap (M USD) 112.98
Shares Outstanding (M) 22.28
30 Day Average Volume 81,234
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TLOG

No data available

Company Profile & Key Executives for TLOG

TetraLogic Pharmaceuticals Corp operates as a biopharmaceutical company. The Company discovers and develops small molecule peptide-mimetic drugs for the treatment of cancers. TetraLogic offers its products throughout the United States.

J Kevin Buchi "Kevin"President/CEOPete A MeyersCFO/Treasurer
Lesley Russell CooperCOO/Chief Medical OfficerC Glenn BegleySenior VP:Research & Dev
More Company Profile & Key Executives for TLOG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil